vmathrudev's profile picture. Live and let live!

Vijayalakshmi Mathrudev

@vmathrudev

Live and let live!

Patient advocacy and support groups in India: focus on lung cancer - The Lancet Regional Health - Southeast Asia thelancet.com/journals/lanse…


Uniqueness of lung cancer in Southeast Asia - The Lancet Regional Health - Southeast Asia thelancet.com/journals/lanse…


Vijayalakshmi Mathrudev reposted

Do register to hear this amazing story

This post is unavailable.

Vijayalakshmi Mathrudev reposted

Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ #headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC

CRSTonline's tweet image. Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ
#headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC
CRSTonline's tweet image. Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ
#headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC
CRSTonline's tweet image. Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ
#headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC
CRSTonline's tweet image. Head-and-neck cancers account for 30-40% of all cancer cases in India. Dr. Prabhash et al. present an update to Indian clinical guidelines for the management of HNSCC. Read here: bit.ly/3UkTTZZ
#headandneckcancer #CRST #CancerTreatment #Cancers #MedTwitter #HNSCC

Management of toxicities from immunotherapy: ESMO Clinical Practice Gu... sciencedirect.com/science/articl…


Phase 3 RCT comparing docetaxel-platinum with docetaxel-platinum-5FU as neoadjuvant chemotherapy in borderline resectable oral cancer - European Journal of Cancer ejcancer.com/article/S0959-…


Our new journal from India is enriching the cancer publications landscape cancerworld.net/our-new-journa… via @CancerWorldmag


Vijayalakshmi Mathrudev reposted

Phase 3 randomized study for evaluation of physician choice Rx and triple metronomic as second-line therapy in head and neck cancer (CRSF 2021-HN-001). Live streaming for ASCO members available at: meetings.asco.org/2023-asco-annu… #proudmoment #india #ASCO #medtwitter #cancerresearch

CRSF_IN's tweet image. Phase 3 randomized study for evaluation of physician choice Rx and triple metronomic as second-line therapy in head and neck cancer (CRSF 2021-HN-001).

Live streaming for ASCO members available at: 
meetings.asco.org/2023-asco-annu…

#proudmoment #india #ASCO #medtwitter #cancerresearch

Vijayalakshmi Mathrudev reposted

So true! 🙌

teachergoals's tweet image. So true! 🙌

Vijayalakshmi Mathrudev reposted

I once met the daughter of a famous cardiologist. I said: that must have been an interesting home to grow up in. She looked sad and said, “The main thing I remember about my childhood is that my Dad was never around.”

This Reddit post hit me hard.

SahilBloom's tweet image. This Reddit post hit me hard.


Vijayalakshmi Mathrudev reposted

What does a career in the field of mental health look like? Come find out! @SangathARG & @CMHLPIndia are hosting a webinar on Careers in Mental Health Research on 1st Jun, 6-7 PM IST. Open and FREE for all. Register now zoom.us/meeting/regist…

SangathIndia's tweet image. What does a career in the field of mental health look like? Come find out!
@SangathARG & @CMHLPIndia are hosting a webinar on Careers in Mental Health Research on 1st Jun, 6-7 PM IST. Open and FREE for all.

Register now zoom.us/meeting/regist…

Vijayalakshmi Mathrudev reposted

Lady Meherbai, the wife of Sir Dorabji Tata, succumbed to #Leukemia in 1931. Sir Dorabji initiated the Tata Memorial Hospital in #memory of his wife. This endeavor opened doors to #research on an international scale in the field of Leukemia and other types of #Cancer.


Vijayalakshmi Mathrudev reposted

This is urgently required even in lmic

The burden of bureaucracy in clinical research has increased for investigators & clinical research teams. ESMO proposes a framework to streamline clinical research & reduce the bureaucracy in clinical trials, promoting better care for cancer patients. 🔗annalsofoncology.org/article/S0923-…

myESMO's tweet image. The burden of bureaucracy in clinical research has increased for investigators & clinical research teams. ESMO proposes a framework to streamline clinical research & reduce the bureaucracy in clinical trials, promoting better care for cancer patients.
🔗annalsofoncology.org/article/S0923-…


Vijayalakshmi Mathrudev reposted

Metrnomic adjuvant after definitive CTRT in HNSCC is it usefull? Read our phase 3 study for the answer. @VanitaNoronha @AnticancerOrgUK @Nandinimenon18 @H_N_C_I_G @DrEzraCohen @DrHaddadRobert @docdcruz @drprathameshpai @venkymd @ashayoncology sciencedirect.com/science/articl…


Vijayalakshmi Mathrudev reposted

the study gives an important message that if something works in pallaitive setting. It is not necessary that it will work in curative setting.

🚨Major Publication: A Phase 3 randomised study showing Oral Metronomic combination failed to improve OS or PFS post-CR after radica chemo radiation thus observation remains standard of care. @DrVijayPatil11 @VanitaNoronha @TheLancet @LancetRH_SEAsia sciencedirect.com/science/articl…

deevyaparekh's tweet image. 🚨Major Publication:

A Phase 3 randomised study showing Oral Metronomic combination failed to improve OS or PFS post-CR after radica chemo radiation thus observation remains standard of care.

@DrVijayPatil11 @VanitaNoronha @TheLancet @LancetRH_SEAsia 

sciencedirect.com/science/articl…


United States Trends

Loading...

Something went wrong.


Something went wrong.